Research

(OCTOBER 18, 2022) Julie Dumas, Ph.D., professor of psychiatry, joined Gayle Guyardo, the host of the nationally syndicated health and wellness show "Bloom," to discuss the impact menopause has on the brain and its connection to Alzheimer’s disease.

In the past several months, cases of polio have been reported in New York, the United Kingdom, and Israel, underscoring the need for safer and more effective vaccines. Over the past nearly two years, University of Vermont Vaccine Testing Center researchers have been conducting trials on two experimental polio vaccines poised to help accomplish global eradication.

The Northern New England Clinical and Translational Research Network has received a $20 million-dollar renewal grant from the National Institutes of Health to continue work to ensure residents in Vermont and Maine – and particularly the elderly, New American and Indigenous populations – receive greater support to address chronic and life-threatening diseases.

For students pursuing a degree in medicine, there’s no off-season. During a two-month break between their first and second years, many Larner College of Medicine medical students tackled projects to address unmet health needs, practice clinical skills, and immerse themselves in specialty clerkships with physician preceptors.

Jason Botten, Ph.D., professor of medicine and associate director of the Vermont Biomedical Research Network, received a University of Vermont SPARK-VT grant to help commercialize his work to develop broad-spectrum antiviral therapeutics, following a faculty pitch competition held in June 2022.

In a Journal of American Medical Association study, researchers - including UVM Professor and UVM Cancer Center member Brian Sprague, Ph.D. - found that 3D screening with digital breast tomosynthesis had certain benefits compared to breast cancer screening with conventional 2D digital mammography.

More than 100 in-person and dozens of virtual participants attended the second annual Vermont Center for Cardiovascular and Brain Health (VCCBH) Symposium, held at the University of Vermont’s Davis Center June 2 to 3, 2022. The VCCBH, one of three National Institutes of Health Center of Biomedical Research Excellence-funded programs at UVM, is co-directed by Mary Cushman, M.D., M.Sc., professor and vice chair for emerging researchers in the Department of Medicine, and Mark Nelson, Ph.D., University Distinguished Professor and chair of the Department of Pharmacology.

A new study, led by University of Vermont Center on Behavior and Health researchers and colleagues and published in JAMA Network Open, found that using a smartphone app that monitored smoking and delivered incentives to participants’ debit cards showed promise in achieving similar results to traditional best practices with financial incentives.

Yvonne Janssen-Heininger, Ph.D., professor of pathology and laboratory medicine at the UVM Larner College of Medicine, is a 2022 recipient of the University Distinguished Professor Award. This title is a career appointment, and is the highest academic honor that UVM can bestow upon a member of the faculty.

Anne Dixon, M.A., BM BCh, professor of medicine, has been named one of four 2022-2023 University Scholars.